Pathogen inactivation of blood derived biological medicines: review article
One of the main sources of a wide range of biological products as starting material is the human blood. These biological human plasma derived medicines play essential role in prevention and treatment of a variety of life threatening diseases. Mention to the starting material of these medicines which...
Main Authors: | Shahnaz Nazari, Majid Shahabi, Kamran Mousavi Hosseini |
---|---|
Format: | Article |
Language: | fas |
Published: |
Tehran University of Medical Sciences
2017-07-01
|
Series: | Tehran University Medical Journal |
Subjects: | |
Online Access: | http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-5583&slc_lang=en&sid=1 |
Similar Items
-
Pathogen Inactivation of Cellular Blood Products—An Additional Safety Layer in Transfusion Medicine
by: Axel Seltsam
Published: (2017-12-01) -
Ultraviolet-Based Pathogen Inactivation Systems: Untangling the Molecular Targets Activated in Platelets
by: Peter Schubert, et al.
Published: (2018-05-01) -
Leukocytes and transfusion related adverse events: the effects of leuko-reduction process in the prevention of adverse reactions resulted from the transfusion of blood components: review article
by: Ehteramolsadat Hosseini, et al.
Published: (2017-05-01) -
Rational Clinical Use of Blood and Blood products – A summary
by: D Ghartimagar
Published: (2017-03-01) -
Whole blood pathogen reduction technology and blood safety in sub-Saharan Africa: A systematic review with regional discussion
by: Asa'ah Nkohkwo, et al.
Published: (2016-06-01)